CME

As of 2026-09-10, CME scores 53out of 100 on QNTM’s five-factor quantitative model, a moderate conviction reading. The score blends momentum, quality, volume, value and sentiment, then adjusts for the current macro regime. CME trades at $274.07, 66% above the band ceiling.

CME scores 53 out of 100 on QNTM's five-factor model — a moderate reading — neither strongly favored nor flagged for weakness at 53. Its strongest factor is value at 66 (strong), where it screens cheap on the model's valuation inputs, followed by quality at 58. The weakest is momentum at 40, where price trend is the soft spot. Among Financials stocks it ranks in roughly the top 26% of the Financials names the model scores.

On valuation, CME is priced near the top of its recent range — the rich end on the model's valuation read. The blended composite before the macro overlay was 53. Same-sector names the model rates nearby include OSCR, MRX, VCTR.

This is a descriptive factor read on CME, recomputed each trading day and shown with its reasoning — not a recommendation to buy, hold or sell. The score reflects where CME sits on the model's measures today, and can change as new data arrives.

FACTOR BREAKDOWN

VALUATION RANGE

QNTM’s descriptive fair-value band for CME runs $124.93–$164.87. Current price $274.07 sits 66% above the band ceiling. This is valuation context, not a price target.

OTHER FINANCIALS NAMES

QNTM provides quantitative model outputs for informational and educational purposes only. It is not investment advice and QNTM is not a registered investment adviser. Scores are rankings, not buy/sell recommendations. Data as of 2026-09-10.